BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  3 Biotechs With Critical Product Launches in 2018

  Biotech companies have a number of pivotal challenges in going from a promising compound to commercially viable products.

  December 11, 2017

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Poached From AstraZeneca, New Pharma Head Looks to Resuscitate GlaxoSmithKline’s Cancer Pipeline

  GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.

  December 11, 2017

   · 

  1 min read
• Deals

  Medtronic Takes Out Crospon in $45M Deal

  Medtronic confirmed that it bought Crospon but declined to disclose the value of the deal.

  December 11, 2017

   · 

  1 min read
• FDA

  Why a FDA Approval for an Accessory Could be a Huge Deal for Apple

  This could be the first step in a long journey that could amount to huge profitability for the iPhone maker.

  December 11, 2017

   · 

  1 min read
• 

  Business

  What You Need to Know About Hyalex Orthopaedics

  Hyalex Orthopaedics launched in May 2017 as a medical device company that intends to advance new products featuring HYALEX technology, a synthetic polymer that mimics cartilage.

  December 11, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Seattle’s PhaseRx Files for Bankruptcy as it Considers Partner, Merger or Sale Options

  The company indicates it plans to continue to manage and operate under the bankruptcy filing while it works with Cowen and Company to develop a plan forward.

  December 11, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Merck Laying Off 50 Employees in North Carolina

  Layoffs are expected to begin in February, according to reports.

  December 11, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Bay Area’s Ardelyx Forges $125M Deal With Fosun Pharma

  The agreement also provides Fosun Pharma the rights to commercialize tenapanor for other indications for which it is approved in the U.S.

  December 11, 2017

   · 

  6 min read
• Policy

  FDA Accepts BLA to Review Eli Lilly’s Galcanezumab for the Prevention of Migraine in Adults

  Lilly announced the submission of the BLA on its third-quarter earnings call in October 2017.

  December 11, 2017

   · 

  5 min read
• Business

  Ionis Pharma Licenses IONIS-HTT Rx to Partner Following Successful Phase I/II Study in Patients With Huntington’s Disease

  Roche will now be responsible for all development and commercial activities.

  December 11, 2017

   · 

  7 min read